Nanoscale drug delivery for targeted chemotherapy

Cancer Lett. 2016 Aug 28;379(1):24-31. doi: 10.1016/j.canlet.2016.05.023. Epub 2016 May 25.

Abstract

Despite significant improvements in diagnostic methods and innovations in therapies for specific cancers, effective treatments for neoplastic diseases still represent major challenges. Nanotechnology as an emerging technology has been widely used in many fields and also provides a new opportunity for the targeted delivery of cancer drugs. Nanoscale delivery of chemotherapy drugs to the tumor site is highly desirable. Recent studies have shown that nanoscale drug delivery systems not only have the ability to destroy cancer cells but may also be carriers for chemotherapy drugs. Some studies have demonstrated that delivery of chemotherapy via nanoscale carriers has greater therapeutic benefit than either treatment modality alone. In this review, novel approaches to nanoscale delivery of chemotherapy are described and recent progress in this field is discussed.

Keywords: Cancer therapy; Chemotherapy; Drug delivery system; Nanotechnology.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / metabolism
  • Drug Carriers*
  • Drug Compounding
  • Drug Delivery Systems / methods*
  • Humans
  • Nanomedicine / methods*
  • Nanoparticles*
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Technology, Pharmaceutical / methods*

Substances

  • Antineoplastic Agents
  • Drug Carriers